OverviewSuggest Edit

Stallergenes Greer is a global biopharmaceutical company specializing in the diagnosis and treatment of respiratory allergies through the development and commercialization of allergy immunotherapy products and services. Our purpose is to enable people with allergies to live normal lives. With more than 1,400 employees worldwide, a presence in 22 countries, and manufacturing facilities in both Europe and the United States, Stallergenes Greer plc is the parent company of GREER Laboratories, Inc. (whose registered office is in the U.S.) and Stallergenes S.A.S. (whose registered office is in France). With complementary strengths, joint heritage and reputations, Stallergenes Greer is driving a continuing leadership in allergy immunotherapy.
TypePublic
Founded2015
HQLondon, GB
Websitestallergenesgreer.com

Latest Updates

Employees (est.) (Feb 2019)1,241
Revenue (FY, 2018)£240 M(+7%)
Share Price (Oct 2017)€44.6

Key People/Management at Stallergenes Greer

Stallergenes Greer

Stallergenes Greer

Chairman and CEO

Stallergenes Greer Office Locations

Stallergenes Greer has offices in London, Boston, Lenoir, Warriewood and in 12 other locations
London, GB (HQ)
TOWER BRIDGE HOUSE, 2 St Katharine's Way, St Katharine's & Wapping
Warriewood, AU
2408/4 Daydream St
Wien, AT
Mariahilfer Str. 103
Lasne, BE
Chaussée de Louvain 277
London, CA
1001 Adelaide St N #201
Antony, FR
6 Rue Alexis de Tocqueville
Show all (20)

Stallergenes Greer Financials and Metrics

Stallergenes Greer Revenue

Stallergenes Greer's revenue was reported to be £239.98 m in FY, 2018
GBP

Revenue (FY, 2018)

240.0m

Gross profit (FY, 2018)

155.2m

Gross profit margin (FY, 2018), %

64.7%

Net income (FY, 2018)

11.1m

EBITDA (FY, 2018)

35.2m

EBIT (FY, 2018)

18.1m

Market capitalization (31-Oct-2017)

868.9m

Closing stock price (31-Oct-2017)

44.6

Cash (31-Dec-2018)

64.1m
Stallergenes Greer's current market capitalization is €868.9 m.
GBPFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Revenue

71.3m163.5m225.4m240.0m

Cost of goods sold

33.1m74.8m81.8m84.8m

Gross profit

38.2m88.6m143.6m155.2m

Gross profit Margin, %

54%54%64%65%
GBPFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

45.0k130.8m62.5m44.0m64.1m

Accounts Receivable

25.8m36.7m28.8m28.6m

Inventories

51.7m55.9m49.2m50.6m

Current Assets

47.4k235.9m176.9m150.8m173.3m
GBPFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

(44.3k)(42.9m)(53.1m)(8.6m)11.1m

Cash From Operating Activities

(13.2k)(33.3m)(68.5m)(3.7m)36.1m

Cash From Financing Activities

66.0k385.0k3.9m(4.0m)(586.4k)

Net Change in Cash

45.0k130.5m(69.1m)(16.5m)19.5m
GBPY, 2018

Revenue/Employee

193.4k

Financial Leverage

1.2 x
Show all financial metrics

Stallergenes Greer Online and Social Media Presence

Embed Graph

Stallergenes Greer News and Updates

Global Allergic Rhinitis Drugs Market Report 2018 Featuring ALK-Abell, GlaxoSmithKline, Merck, Sanofi & Stallergenes Greer

DUBLIN, Jan. 7, 2019 /PRNewswire/ -- The "Global Allergic Rhinitis Drugs Market 2019-2023" report has been added to ResearchAndMarkets.com's offering. The allergic rhinitis drugs market will register a CAGR of close to 4% by 2023. The rise in R&D of new therapies is expected to drive...

Global Allergy Immunotherapies Markets to 2023 with ALK, Allergy Therapeutics, HAL Allergy, Merck, and Stallergenes Greer Leading the Competition

DUBLIN, Dec 7, 2018 /PRNewswire/ -- The "Global Allergy Immunotherapies Market 2019-2023" report has been added to ResearchAndMarkets.com's offering. The allergy immunotherapies market is forecast register a CAGR of more than 7% by 2023. The latest trend gaining momentum in the market is...

Stallergenes Greer Blogs

Stallergenes Greer and Anergis Initiate New Study to Predict Efficacy of Second-Generation Allergen Immunotherapy

News Item ID:  20191017005382 PDF url:  http://stallergenesgreer.com/sites/default/files/Attachements/stallergenes_greer_anergis_initiate_new_study_en.pdf

STALLERGENES GREER ET ANERGIS LANCENT UNE NOUVELLE ÉTUDE PORTANT SUR L’EFFICACITÉ DE L’IMMUNOTHÉRAPIE ALLERGÉNIQUE DE DEUXIÈME GÉNÉRATION

News Item ID:  20191017005383 PDF url:  https://mms.businesswire.com/media/20191017005383/fr/750313/1/Stallergenes_Greer_%26_Anergis_Initiate_New_Study_FR.pdf

STALLERGENES GREER PARTICIPERA AU CONGRÈS 2019 DE L’EAACI ET PRÉSENTERA LES RÉSULTATS DE L’ESSAI CLINIQUE DE PHASE III PORTANT SUR SON COMPRIMÉ AUX ACARIENS

News Item ID:  20190531005015 PDF url:  https://mms.businesswire.com/media/20190531005015/fr/723989/1/EAACI_2019_FR.pdf

Stallergenes Greer Will Be at 2019 EAACI Congress and Present the Results of Its Phase III House Dust Mites Tablet Trial

News Item ID:  20190531005014 PDF url:  https://mms.businesswire.com/media/20190531005014/en/723990/1/EAACI_2019_EN.pdf

ACQUISITION EN NUMÉRAIRE RECOMMANDÉE ("RECOMMENDED CASH ACQUISITION") DE STALLERGENES GREER PLC PAR ARES LIFE SCIENCES I S.À R.L.

News Item ID:  20190516005418 PDF url:  https://mms.businesswire.com/media/20190516005418/fr/722172/1/IR_Stallergenes_Greer-Scheme_Effective_Announcement_FR.pdf

Recommended Cash Acquisition of Stallergenes Greer plc by Ares Life Sciences I S.à r.l.

News Item ID:  20190516005417 PDF url:  https://mms.businesswire.com/media/20190516005417/en/722171/1/IR_Stallergenes_Greer-Scheme_Effective_Announcement_EN.pdf
Show more

Stallergenes Greer Frequently Asked Questions

  • When was Stallergenes Greer founded?

    Stallergenes Greer was founded in 2015.

  • Who are Stallergenes Greer key executives?

    Stallergenes Greer's key executives are Stallergenes Greer.

  • How many employees does Stallergenes Greer have?

    Stallergenes Greer has 1,241 employees.

  • What is Stallergenes Greer revenue?

    Latest Stallergenes Greer annual revenue is £240 m.

  • What is Stallergenes Greer revenue per employee?

    Latest Stallergenes Greer revenue per employee is £193.4 k.

  • Who are Stallergenes Greer competitors?

    Competitors of Stallergenes Greer include Hikma Pharmaceuticals, Bausch Health Companies and Cytokinetics.

  • Where is Stallergenes Greer headquarters?

    Stallergenes Greer headquarters is located at TOWER BRIDGE HOUSE, 2 St Katharine's Way, St Katharine's & Wapping, London.

  • Where are Stallergenes Greer offices?

    Stallergenes Greer has offices in London, Boston, Lenoir, Warriewood and in 12 other locations.

  • How many offices does Stallergenes Greer have?

    Stallergenes Greer has 20 offices.